Quick Answer
Journey Medical Corp reported Net Income Loss of -$11.43 million for the year ending 2025.
- Journey Medical Corp showed an increase of +22.1% in Net Income Loss from 2024 to 2025.
- This data is from Journey Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Journey Medical Corp's Net Income Loss has declined by 316.4%.
- Historical annual values: Fiscal year 2025: -$11.43 million | Fiscal year 2024: -$14.67 million | Fiscal year 2023: -$3.85 million | Fiscal year 2022: -$29.63 million | Fiscal year 2021: -$43.99 million | Fiscal year 2020: $5.28 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: